CDMO

Polpharma API CDMO (Contract Development and Manufacturing Organization) supports emerging and large pharmaceutical customers in the development and commercialization of their small-molecule APIs clinical candidates thanks to +70 years of experience in process development, scale-up, and cGMP manufacturing of small molecule APIs in volumes ranging from kilos to tens of tons.

We manufacture our products by following our customers’ and health authorities’ most stringent requirements.

Facilities for the production of APIs undergo rigorous inspections from the U.S. Food and Drug Administration (FDA). Our multipurpose plant passed FDA inspections in 2004, 2009, 2012, 2015, and, most recently, May 2018. This is something we are proud of and that confirms the highest quality standards of Polpharma.

Polpharma

USFDA

Polpharma

EDQM/EMA

Polpharma

Local MOH

Polpharma

SKFDA

Polpharma

ANVISA

Polpharma

PMDA

We supply APIs for pharmaceutical companies worldwide.

Polpharma

With a competitive cost of production, superior product quality and environmentally friendly processes API Polpharma is a significant European manufacturer.

As part of our commitment to provide the highest CDMO service, we put the greatest emphasis on:

Documentation in an eCTD format and CEP certificates

Specifications for every stage of production

Qualification and audits of suppliers

Quick response to complaints

System procedures

Compliance with cGMP

On-the-job GMP training

Validation and qualifications of equipment and production processes